Lake Street analyst Jacob Stephan raised the firm’s price target on Paysign (PAYS) to $10 from $9 and keeps a Buy rating on the shares after the company reported a beat and raise quarter. Paysign is “in the early innings of an inflection in pharma revenues,” according to the analyst, who believes “investors should take note.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAYS:
